Nutra Pharma Corp. (NPHC)

Nutra Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.41	0.59	0.44	0.1	0.05	0.1
Revenue Growth (YoY)	-40.00%	35.73%	348.43%	88.33%	-50.29%	-20.06%
Cost of Revenue	0.15	0.2	0.19	0.09	0.04	0.07
Gross Profit	0.25	0.4	0.25	0.01	0.01	0.03
Selling, General & Admin	1.09	1.18	2.08	1.93	1.1	1.2
Operating Expenses	1.09	1.28	2.16	2	0.94	1.26
Operating Income	-0.84	-0.89	-1.91	-1.99	-0.92	-1.23
Interest Expense	-0.34	-0.4	-0.79	-0.5	-0.34	-0.26
Other Non Operating Income (Expenses)	-0.14	-0.11	11.03	-10.13	-1.1	-5.19
EBT Excluding Unusual Items	-1.32	-1.4	8.33	-12.61	-2.36	-6.68
Other Unusual Items	0.02	0.01	-0.15	-0.49	1.59	0.09
Pretax Income	-1.3	-1.39	8.18	-13.1	-0.77	-6.59
Net Income	-1.3	-1.39	8.18	-13.1	-0.77	-6.59
Net Income to Common	-1.3	-1.39	8.18	-13.1	-0.77	-6.59
Shares Outstanding (Basic)	7,645	7,608	7,503	7,233	6,607	4,710
Shares Outstanding (Diluted)	7,645	7,608	19,097	7,233	6,607	4,710
Shares Change (YoY)	-43.24%	-60.16%	164.03%	9.46%	40.28%	47.78%
EPS (Basic)	-0.00	-0.00	0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	0.00	-0.00	-0.00	-0.00
Free Cash Flow	-0.43	-0.55	-0.82	-1.78	-0.88	-0.74
Gross Margin	62.71%	66.64%	56.82%	8.66%	28.74%	33.25%
Operating Margin	-206.96%	-149.10%	-435.21%	-2034.53%	-1782.27%	-1178.14%
Profit Margin	-319.85%	-234.22%	1865.70%	-13399.01%	-1482.14%	-6314.07%
Free Cash Flow Margin	-106.46%	-92.46%	-187.19%	-1824.84%	-1703.36%	-712.37%
EBITDA	-0.83	-0.87	-1.88	-1.98	-0.92	-1.23
EBITDA Margin	-205.13%	-146.05%	-	-	-	-
D&A For EBITDA	0.01	0.02	0.02	0.01	0	0
EBIT	-0.84	-0.89	-1.91	-1.99	-0.92	-1.23
EBIT Margin	-206.96%	-149.10%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.